Protein detail

S22A6

Solute carrier family 22 member 6 (Organic anion transporter 1) (hOAT1) (PAH transporter) (hPAHT) (Renal organic anion transporter 1) (hROAT1)

Entry name
S22A6
UniProt ID
EVMP confidence score
0.38
Supporting publications (n)
Transmembrane count
12
Protein classification
FDA approved drug targetsMetabolic proteinsPredicted membrane proteinsTransporters
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information12
Protein Names
Solute carrier family 22 member 6 (Organic anion transporter 1) (hOAT1) (PAH transporter) (hPAHT) (Renal organic anion transporter 1) (hROAT1)
Protein Class (4)
FDA approved drug targetsMetabolic proteinsPredicted membrane proteinsTransporters
Protein Function (2)
  • Transporters:Electrochemical Potential-driven transporters
  • FDA approved drug targets:Small molecule drugs
Transmembrane
10..30; Helical; 136..156; Helical; 165..187; Helical; 191..213; Helical; 225..245; Helical; 249..269; Helical; 338..358; Helical; 369..389; Helical; 396..416; Helical; 426..446; Helical; 456..475; Helical; 485..505; Helical
Transmembrane Count
12
Entrez Gene Symbol
Gene Synonym (3)
OAT1PAHTROAT1
Gene Description
Solute carrier family 22 member 6
Chromosome
11
Position
62936385-62984967
EVMP confidence score
0.38
Fluorescence & Localization4
Tissue SpecificbrainCell SpecificBergmann gliaBlood Cell Specificplasmacytoid DCBlood Lineage Specificdendritic cells
Function & Pathway7
Relations & Evidence23

Ligand-Receptor Signaling (22)

22 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
transmembranetransmembraneTopDBNoNoNoNoNo
transmembranetransmembraneLOCATENoNoNoNoNo
transmembranetransmembraneRamilowski_locationNoNoNoNoNo
transmembranetransmembraneOmniPathNoNoNoNoNo
plasma_membraneplasma_membraneUniProt_locationNoNoNoNoNo
basolateral_cell_membraneplasma_membraneUniProt_locationNoNoNoNoNo
basal_cell_membraneplasma_membraneUniProt_locationNoNoNoNoNo
plasma_membraneplasma_membraneOmniPathNoNoNoNoNo
cell_surfacecell_surfaceSurfaceomeNoNoNoNoNo
cell_surfacecell_surfaceOmniPathNoNoNoNoNo
Page 2 of 3PreviousNext

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationUltrafiltration / Tangential Flow FiltrationData-Dependent Acquisition LC-MS/MS132795414
Sequence, Structure & Domains10

Sequences

Length
563
Mass
61,816
Sequence
MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCRPPADANLSKNGGLEVWLPRDRQGQPESCLRFTSPQWGLPFLNGTEANGTGATEPCTDGWIYDNSTFPSTIVTEWDLVCSHRALRQLAQSLYMVGVLLGAMVFGYLADRLGRRKVLILNYLQTAVSGTCAAFAPNFPIYCAFRLLSGMALAGISLNCMTLNVEWMPIHTRACVGTLIGYVYSLGQFLLAGVAYAVPHWRHLQLLVSAPFFAFFIYSWFFIESARWHSSSGRLDLTLRALQRVARINGKREEGAKLSMEVLRASLQKELTMGKGQASAMELLRCPTLRHLFLCLSMLWFATSFAYYGLVMDLQGFGVSIYLIQVIFGAVDLPAKLVGFLVINSLGRRPAQMAALLLAGICILLNGVIPQDQSIVRTSLAVLGKGCLAASFNCIFLYTGELYPTMIRQTGMGMGSTMARVGSIVSPLVSMTAELYPSMPLFIYGAVPVAASAVTVLLPETLGQPLPDTVQDLESRWAPTQKEAGIYPRKGKQTRQQQEHQKYMVPLQASAQEKNGL
Alternative Products
Event=Alternative splicing; Named isoforms=4; Name=1; Synonyms=OAT1-1; IsoId=Q4U2R8-1; Sequence=Displayed; Name=2; Synonyms=OAT1-2; IsoId=Q4U2R8-2; Sequence=VSP_032169; Name=3; Synonyms=OAT1-3; IsoId=Q4U2R8-3; Sequence=VSP_032168, VSP_032169; Name=4; Synonyms=OAT1-4; IsoId=Q4U2R8-4; Sequence=VSP_032168
Alternative Sequence
455..498; Missing (in isoform 3 and isoform 4); 523..535; Missing (in isoform 2 and isoform 3)

3D Structural Models

3D Structure
Electron microscopy (8)

Domain & Motif Annotations

Domain (CC)
Multiple cysteine residues are necessary for proper targeting to the plasma membrane.
Region
525..563; Disordered
Protein Families (2)
  • Major facilitator (TC 2.A.1) superfamily
  • Organic cation transporter (TC 2.A.1.19) family
Sequence Similarities
Belongs to the major facilitator (TC 2.A.1) superfamily. Organic cation transporter (TC 2.A.1.19) family.
Clinical Relevance4
Disease Involvement
FDA approved drug targets
Drug Targets
FDA approved drug targets